drug protocol number

CBYL719C2202

drug sponsor

Novartis Saudi Limited

drug study

BYL719 / Alpelisib

drug trial site

King Fahad Specialist Hospital (Dammam),King Khalid University Hospital (Riyadh)

drug status

Completed

drug phase